netFormulary NHS
Milton Keynes Formulary
Milton Keynes University Hospital NHS Foundation Trust
Milton Keynes Clinical Commissioning Group
Milton Keynes Community Health Services
 Search
 Formulary Chapter 15: Anaesthesia - Full Chapter
15.01.03  Expand sub section  Antimuscarinic drugs
Atropine Sulphate
(injection)
View adult BNF View SPC online View childrens BNF
Formulary
Amber 2

600 micrograms in 1ml amp (Hospital Only)

  • 1mg in 5ml PFS
  • 3mg in 10ml PFS
  • 600 micrograms in 1ml PFS
  • 1mg in 10ml Min-I-Jet
  • 3mg in 30ml Min-I-Jet
  • 500 micrograms 5ml Min-I-Jet

     

 
   
Glycopyrronium Bromide
(injection (Glycopyrrolate))
View adult BNF View SPC online View childrens BNF
Formulary
Amber 2
  • 200 micrograms in 1mL amp
  • 600 micrograms in 3mL amp
 
   
Hyoscine Hydrobromide
(injection)
View adult BNF View SPC online View childrens BNF
Formulary
Amber 2
  • 400 micrograms in 1ml amps
  • 600 micrograms in 1ml amps
 
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Green

Routine prescribing within licensed indication  

Amber 1

Specialist recommendation followed by GP initiation and continuation  

Amber 2

Specialist or GP initiation in line with local guideline after 1st line failure followed by GP continuation   

Amber 3

Specialist initiation and stabilisation followed by GP continuation  

Amber SCG

Specialist initiation and stabilisation followed by GP continuation in line with an agreed shared care guideline  

Red

Hospital or specialist prescribing only  

Red Red

These medicines have been evaluated and rejected by MKPAG and are NOT approved for use within MK. They are not recommended for use because of lack of clinical effectiveness, cost effectiveness or safety.  

netFormulary